Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications
Masae Iwasaki, Junichi Saito, Hailin Zhao, et al.
Inflammation (2020) Vol. 44, Iss. 1, pp. 13-34
Open Access | Times Cited: 206

Showing 1-25 of 206 citing articles:

Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity
Joseph Mercola, William B. Grant, Carol L. Wagner
Nutrients (2020) Vol. 12, Iss. 11, pp. 3361-3361
Open Access | Times Cited: 260
SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration
Ling Zhang, Li Zhou, Linlin Bao, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 245
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
Lore Vanderbeke, Pierre Van Mol, Yannick Van Herck, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 217
Long-Lasting Cognitive Abnormalities after COVID-19
Roberta Ferrucci, Michelangelo Dini, Elisabetta Groppo, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 235-235
Open Access | Times Cited: 176
Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases
George El-Arif, Shaymaa Khazaal, Antonella Farhat, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2048-2048
Open Access | Times Cited: 71
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 69
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives
Shubhadeep Roychoudhury, Anandan Das, Pallav Sengupta, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 24, pp. 9411-9411
Open Access | Times Cited: 123
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
Angela E. Peter, B. V. Sandeep, B. Ganga Rao, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 84
The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review
Yi‐Chou Hou, Kuo‐Cheng Lu, Ko‐Lin Kuo
Vaccines (2021) Vol. 9, Iss. 8, pp. 885-885
Open Access | Times Cited: 68
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 64
Effects of COVID-19 on the Musculoskeletal System: Clinician’s Guide
Laith K. Hasan, Brittney Deadwiler, Aryan Haratian, et al.
Orthopedic Research and Reviews (2021) Vol. Volume 13, pp. 141-150
Open Access | Times Cited: 61
The role of cell death in SARS-CoV-2 infection
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies
Ruth C. E. Bowyer, Charlotte F. Huggins, Renin Toms, et al.
European Journal of Epidemiology (2023) Vol. 38, Iss. 2, pp. 199-210
Open Access | Times Cited: 27
COVID-19 and atrial fibrillation: Intercepting lines
Maria Donniacuo, Antonella De Angelis, Concetta Rafaniello, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Non-Thermal Plasma as a Novel Strategy for Treating or Preventing Viral Infection and Associated Disease
Hager Mohamed, Gaurav Nayak, Nicole Rendine, et al.
Frontiers in Physics (2021) Vol. 9
Open Access | Times Cited: 50
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska, Marta Baranowska‐Kuczko, Aleksandra Kicman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1986-1986
Open Access | Times Cited: 46
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)
Hung‐Chi Yang, Tian‐Hsiang Ma, Wen-Ye Tjong, et al.
Free Radical Research (2021) Vol. 55, Iss. 4, pp. 364-374
Open Access | Times Cited: 41
Targeting immunometabolism to treat COVID-19
Shane M. O’Carroll, Luke O'neill
Immunotherapy Advances (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 40
The immune response to COVID‐19: Does sex matter?
Jim Q. Ho, Mohammad Reza Sepand, Banafsheh Bigdelou, et al.
Immunology (2022) Vol. 166, Iss. 4, pp. 429-443
Open Access | Times Cited: 34
The potential impact of Covid-19 on CNS and psychiatric sequels
Ali Dehghani, Elham Zokaei, Seyyed Mohammad Kahani, et al.
Asian Journal of Psychiatry (2022) Vol. 72, pp. 103097-103097
Open Access | Times Cited: 32
Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review
Weihang He, Xiaoqiang Liu, Bing Hu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
SARS-CoV-2 envelope protein induces necroptosis and mediates inflammatory response in lung and colon cells through receptor interacting protein kinase 1
Budhadev Baral, Vaishali Saini, A Tandon, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1596-1617
Closed Access | Times Cited: 18
Effectiveness of Antiviral Therapy on Long COVID: A Systematic Review and Meta-Analysis
Yu Jung Choi, Yu Bin Seo, Jun-Won Seo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7375-7375
Open Access | Times Cited: 17
Dementia, infections and vaccines: 30 years of controversy
Fiona Ecarnot, Virginia Boccardi, Andrea Calcagno, et al.
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 6, pp. 1145-1160
Open Access | Times Cited: 16
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top